1. Chen X.S., Y.P. Yin, G.J. Liang, et al. Sexually transmitted infections among female sex workers in Yunnan, China. AIDS Patient Care STDS, 2005. 19(12): p. 853-60. 2. Ngo T.D., O. Laeyendecker, C. Li, et al. Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China. Int J STD AIDS, 2008. 19(10): p. 694-7. 3. Lama J.R., A. Lucchetti, L. Suarez, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis, 2006. 194(10): p. 1459-66. 4. Kapiga S.H., N.E. Sam, H. Bang, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis, 2007. 195(9): p. 1260-9. 5. Celum C.L. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes, 2004. 11 Suppl 1: p. 36A-45A. 6. Wald A. and K. Link. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis, 2002. 185(1): p. 45-52. 7. Tan D.H., R. Kaul, and S. Walsmley. Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV? Can J Infect Dis Med Microbiol, 2009. 20(1): p. e1-7. 8. Brown J.M., A. Wald, A. Hubbard, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS, 2007. 21(12): p. 1515-23. 9. Kaul R., C. Pettengell, P.M. Sheth, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol, 2008. 77(1): p. 32-40. 10. Mosca J.D., P.M. Pitha, and G.S. Hayward. Herpes simplex virus infection selectively stimulates accumulation of beta interferon reporter gene mRNA by a posttranscriptional mechanism. J Virol, 1992. 66(6): p. 3811-22. 11. Diaz J.J., M.D. Dodon, N. Schaerer-Uthurralt, et al. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature, 1996. 379(6562): p. 273-7. 12. Van de Perre P., M. Segondy, V. Foulongne, et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis, 2008. 8(8): p. 490-7. 13. DaPalma T., B.P. Doonan, N.M. Trager, et al. A systematic approach to virus-virus interactions. Virus Res, 2010. 149(1): p. 1-9. 14. Chen C.Y., R.C. Ballard, C.M. Beck-Sague, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis, 2000. 27(1): p. 21-9. 15. Rebbapragada A., C. Wachihi, C. Pettengell, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS, 2007. 21(5): p. 589-98. 16. Aumakhan B., C.A. Gaydos, T.C. Quinn, et al. Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers. PLoS One, 2010. 5(4): p. e9973. 17. Rodriguez B., A.K. Sethi, V.K. Cheruvu, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA, 2006. 296(12): p. 1498-506. 18. Nagot N., A. Ouedraogo, V. Foulongne, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med, 2007. 356(8): p. 790-9. 19. Baeten J.M., L.B. Strick, A. Lucchetti, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis, 2008. 198(12): p. 1804-8. 20. Delany S., N. Mlaba, T. Clayton, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS, 2009. 23(4): p. 461-9. 21. Zuckerman R.A., A. Lucchetti, W.L. Whittington, et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS, 2009. 23(4): p. 479-83. 22. Modjarrad K. and S.H. Vermund. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis, 2010. 10(7): p. 455-63. 23. Lingappa J.R., J.M. Baeten, A. Wald, et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet, 2010. 375(9717): p. 824-33. 24. Lingappa J.R., E. Kahle, N. Mugo, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One, 2009. 4(4): p. e5272. 25. Celum C., A. Wald, J.R. Lingappa, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med, 2010. 362(5): p. 427-39. 26. Watson-Jones D., H.A. Weiss, M. Rusizoka, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med, 2008. 358(15): p. 1560-71. 27. Zhu J., F. Hladik, A. Woodward, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med, 2009. 15(8): p. 886-92.